Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9617511
Tissue-specific differentiation matrices and uses thereof
granted patentUS 9616076
Methods for treating viral infections using hydrogen sulfide donors
granted patentUS 9616048
Anti-depression compounds
granted patentUS 9611266
Compounds and anti-tumor NQO1 substrates
granted patentUS 9611292
Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction
granted patentUS 9605057
Endotrophin neutralization and use thereof
granted patentUS 9603896
Peptide compounds and methods of production and use thereof
granted patentUS 9603945
Heparosan polymers and methods of making and using same for the enhancement of therapeutic
granted patentUS 9598694
Micro-RNAs involved in macular degeneration
granted patentUS 9598697
Recombinant bacterium to decrease tumor growth
granted patentUS 9592238
Anti-ceramide monoclonal antibody 2A2
granted patentUS 9593080
Triazabutadienes as cleavable cross-linkers
granted patentUS 9593131
Copper-cysteamine and methods of use
granted patentUS 9585910
Polymers functionalized with ion-specific recognition elements
granted patentUS 9585954
Mucosal immunization
granted patentUS 9579370
Compositions and methods for enterohemorrhagic Escherichia coli (EHEC)vaccination
granted patentUS 9580472
Anti-microbial peptides and methods of use thereof
granted patentUS 9580718
Attenuated live bacteria with increased acid resistance and methods of use thereof
granted patentUS 9580690
Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereo
granted patentUS 9572828
Treatment for melanoma
granted patentUS 9573906
Therapeutic compounds
granted patentUS 9574191
Selective inhibition of polyglutamine protein expression
granted patentUS 9566320
Mucin-associated surface protein as vaccine against Chagas disease
granted patentUS 9566310
Methods of treating muscular dystrophy
granted